Shu Wen Li
Direktor/Vorstandsmitglied bei Impax Laboratories (Taiwan), Inc.
Profil
Shu Wen Li currently works for Impax Laboratories (Taiwan), Inc. as a Member-Supervisory Board member.
Currently, Mr. Li holds the position of Member-Supervisory Board at Impax Laboratories (Taiwan), Inc.
Aktive Positionen von Shu Wen Li
| Unternehmen | Position | Beginn |
|---|---|---|
Impax Laboratories (Taiwan), Inc.
 Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan. | Direktor/Vorstandsmitglied | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Impax Laboratories (Taiwan), Inc.
Impax Laboratories (Taiwan), Inc. Pharmaceuticals: MajorHealth Technology Impax Laboratories (Taiwan), Inc. engages in the research, development and manufacturing of oral controlled-release dosage forms of generic drugs. It also involves in the formulation and clinical development of alternate dosage forms of drugs for diseases in the central nervous system. Its products include branded pharmaceutical product such as IPX066 and generic pharmaceutical products such as Acarbose, Dantrolene Sodium, and Fenofibrate tablets. The company was founded on May 4, 2007 and is headquartered in Miaoli, Taiwan. | Health Technology |
